PierreBarthélemy

Counsel

Paris + 33.1.56.59.38.67

Spécialisé en droit public des affaires, Pierre Barthélemy intervient notamment sur les problématiques de commande publique et, en particulier, sur la passation, le financement et l’exécution de marchés publics (en ce compris les marchés de partenariat ou contrats de partenariat), de concessions (délégations de service public, affermages, etc.) et de contrats complexes (BEA, AOT, etc.). Il conseille des opérateurs privés, des prêteurs (banques) ou des pouvoirs adjudicateurs/entités adjudicatrices.

Pierre Barthélemy accompagne aussi les entreprises françaises et internationales en matière de régulation des activités économiques. Son activité couvre notamment la régulation sectorielle nationale et européenne dans les secteurs de l'énergie (électricité et gaz, production, fourniture, transport, stockage, distribution) et des transports (ferroviaire, routier, services réguliers ou occasionnels). Elle couvre aussi les opérations commerciales et transactionnelles : contrôle des investissements étrangers en France et en Europe (demandes d’autorisations, de rescrits, etc.), des exportations-importations et des investissements dans des pays sujets à sanctions françaises ou internationales. Il intervient également en matière de privatisation.

Il s’implique aussi sur les problématiques de domanialité publique, notamment en lien avec des activités économiques, et d’urbanisme (montages complexes, expropriation, permis de construire).

Il pratique aussi bien le conseil que le contentieux devant les juridictions administratives et constitutionnelle.

Avant de rejoindre Jones Day, Pierre Barthélemy a exercé au sein d’un cabinet français.

Expérience

  • Amolyt Pharma acquired by AstraZenecaJones Day advised Amolyt Pharma, a global, clinical-stage biopharmaceutical company specializing in developing therapeutic peptides for rare endocrine and related diseases, in its $1.05 billion acquisition by AstraZeneca.
  • Silver Lake Waterman, Eurazeo, Partech Partners, Eight Roads, F-Prime, and Serena Capital participate in $54 million Series C financing of OdasevaJones Day advised Silver Lake Waterman, the lead new investor, and Eurazeo, a new investor, as well as historical investors Partech Partners, Eight Roads, F-Prime and Serena Capital in connection with the $54 million Series C financing of Odaseva, the leading enterprise data security platform for Salesforce, along with new investor Crescent Cove.
  • Société Générale sells Société Générale Equipment Finance's (SGEF) activitiesJones Day is advising Société Générale in the sale of the professional equipment financing businesses operated by Societe Generale Equipment Finance (SGEF) to Groupe BPCE.
  • Silicon Mobility sold to IntelJones Day advised Silicon Mobility SAS in the acquisition of the company by Intel Corporation.
  • Sanofi sells portfolio of well-established consumer healthcare brands to STADAJones Day advised Sanofi in the sale of a portfolio of 7 well-established consumer healthcare brands across several countries, including Belgium, Germany, Hungary, Spain, the U.K., as well as Nordic countries, to STADA Arzneimittel AG.
  • Arverne Group combines with Transition to publicly list on Euronext Paris the future French leader in geothermal and low-carbon lithium to drive energy transitionJones Day advised Arverne Group SAS, a French company ("Arverne"), in its business combination with Euronext listed Transition SA to create the future French leader in geothermal and low-carbon lithium production.
  • Orano and XTC New Energy create two JVs dedicated to the production of batteries for electric vehiclesJones Day is advising Orano in the context of the setting-up of two joint-ventures dedicated to the production of critical materials for batteries for electric vehicles, together with Chinese group XTC New Energy.
  • True Green Capital Management invests in Faradae SASJones Day advised True Green Capital Management LLC in the acquisition of a controlling interest in Faradae SAS, an independent renewable power producer based in Lyon, France, that targets French real estate investment trusts ("REITs") and other corporate customers for solar installations.
  • TotalEnergies' affiliate Cray Valley sells three product lines to Pacific Avenue Capital PartnersJones Day is advising Total Energies on its sale of three product lines to Pacific Avenue Capital Partners (Wingtack®, PolyBD® and Dymalink®) developed by Cray Valley, its resin production and sales affiliate.
  • RATP Développement secures €450 million concession contract before French administrative courtJones Day successfully represented RATP Développement, a subsidiary of RATP, against its competitor Transdev before the administrative court of Toulon on the awarding of a 6-years and €450 million concession contract related to the public transportation system of Métropole Toulon Provence Méditerranée.
  • Uniphore Technologies acquires HexagonJones Day advised Uniphore Technologies, a provider of conversational artificial intelligence and automation, in the acquisition of Hexagone, which fuses voice, visual, and text-based data to provide AI-derived insights to help better understand human behavior.
  • Sanofi sells customer healthcare products to ZentivaJones Day advised Sanofi in the sale of a portfolio of 12 customer healthcare products marketed in Europe to Zentiva K.S, a multinational pharmaceutical company headquartered in Prague, Czech Republic.
  • Swile and Groupe BPCE to combine to create global leader in employee benefitsJones Day advised Swile, a worktech unicorn, in the acquisition of Bimpli, a subsidiary of Groupe BPCE and leader in employee services and benefits in France.
  • Ansys acquires automotive simulation channel partner DYNAmoreJones Day is representing Ansys, Inc. in the acquisition of the DYNAmore business (“DYNAmore”), a Stuttgart, Germany-headquartered company who has historically distributed Ansys’ LS-DYNA crash test simulation software to virtually all major European car manufacturers.
  • Armor sells stake in ARMOR-IIMAK to AstorgJones Day advised EN5, controlling shareholders of the Armor group, on the management buyout of Armor Iimak group and the simultaneous 40% investment by Astorg Midcap in the Armor Iimak group.
  • STERIS acquires Cantel Medical for $3.6 billionJones Day advised STERIS plc in its acquisition of Cantel Medical Corp, a global provider of infection prevention products and services primarily to endoscopy and dental customers, for $3.6 billion.
  • Koch Equity Development acquires Transaction Network ServicesJones Day advised Koch Equity Development LLC, the acquisition and investment subsidiary of Koch Industries, Inc., in the acquisition of Transaction Network Services, Inc. (TNS) from affiliates of Siris Capital Group, LLC and TNS' other minority equity holders.
  • HealthHero acquires QareJones Day advised HealthHero in its acquisition of Qare, a French platform that provides medical video consultation services, backed by Kamet Ventures.
  • Verizon Media forms partnership with BuzzFeed to acquire HuffPostJones Day advised Verizon Media in its sale of HuffPost to BuzzFeed.
  • Smith & Nephew acquires Extremity Orthopedics business of Integra LifeSciences Holdings Corporation for $240 millionJones Day advised Smith & Nephew plc, the global medical technology company, in its acquisition of the Extremity Orthopedics business of Integra LifeSciences Holdings Corporation (NASDAQ: IART) for $240 million on a cash and debt-free basis.